Most bladder cancers are a type called urothelial cancer. But there are many rare histologic types, called variants. Some examples are squamous cell carcinoma, adenocarcinoma, micropapillary, ...

High-risk, non-muscle-invasive bladder cancer is defined as any transitional ... Other indications for radical cystectomy are micropapillary disease (a particularly aggressive variant of TCC ...

Metastatic urothelial cancer exhibits substantial molecular heterogeneity compared with the primary tumour, complicating the development of accurate biomarkers. Pre-treatment metastatic biopsies ...

Venous closure devices, GLP1-s linked to blindness and cancer, resisting the urge to do an ECG, and transcatheter edge-to-edge repair (TEER) for secondary mitral regurgitation are the topics ...

There are many treatment options for bladder cancer, which vary depending on the stage and type of bladder cancer you have, your overall health, and your preferences. These include various types ...

Standard treatment for muscle-invasive bladder cancer is neoadjuvant chemotherapy followed by radical cystectomy, but more than half of all patients relapse within 3 years. Previous trials of ...

Oct. 9, 2024 — How bladder cancer originates and progresses has been illuminated as never before. Researchers found that antiviral enzymes that mutate the DNA of normal and cancer cells are key ...

Many other health problems can also cause these signs. If you have any of these signs, see your doctor as soon as possible. Learn more about bladder cancer from the National Cancer Institute. Image of ...

After falling short in a confirmatory clinical trial, Gilead Sciences has decided to withdraw Trodelvy as a bladder cancer treatment in the U.S. The California biotech announced the decision ...

(Reuters) -Gilead Sciences said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of bladder cancer after it failed to meet the main goal in a confirmatory trial.